Surgery Partners (SGRY) Cash from Investing Activities (2014 - 2026)

Surgery Partners (SGRY) has 13 years of Cash from Investing Activities data on file, last reported at -$13.4 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 82.46% year-over-year to -$13.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$183.6 million (up 61.89% YoY) and the FY2025 annual result came in at -$246.6 million, up 49.52% from the prior year.
• Cash from Investing Activities grew to -$13.4 million in Q1 2026 per SGRY's latest filing, from -$126.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $2.1 million in Q2 2025, with the low at -$244.1 million in Q2 2024.
• Average Cash from Investing Activities over 5 years is -$75.4 million, with a median of -$70.7 million recorded in 2023.
• Year-over-year, Cash from Investing Activities slumped 408.71% in 2022 and surged 100.86% in 2025.
• Surgery Partners' Cash from Investing Activities stood at -$72.2 million in 2022, then grew by 19.53% to -$58.1 million in 2023, then slumped by 92.25% to -$111.7 million in 2024, then retreated by 12.89% to -$126.1 million in 2025, then jumped by 89.37% to -$13.4 million in 2026.
• Business Quant data shows SGRY's Cash from Investing Activities at -$13.4 million in Q1 2026, -$126.1 million in Q4 2025, and -$46.2 million in Q3 2025.